The Body: The Complete HIV/AIDS Resource
Follow Us Follow Us on Facebook Follow Us on Twitter Download Our App 
Professionals >> Visit The Body PROThe Body en Espanol
Ask the Experts About

Choosing Your MedsChoosing Your Meds
Rollover images to visit our other forums!
Recent AnswersAsk a Question
  • Email Email
  • Glossary Glossary

Outlook in next 3-5 years

Dec 21, 2005

As many of us expect to do well with current treatments over the next few years I want to ask what you perceive to be the most significant changes in treatment in the coming pipeline - beyond the important but expected increase in new drug agents within the current classes? I see so much on the internet and in the news (therapeutic vaccines, immune systemn enhancers etc) but value a real medical point of view in what is really important and might be expected to increase our quality of lives.

Response from Dr. Pierone

In my opinion the most significant changes in the coming pipeline will be new classes of HIV medications like integrase and maturation inhibitors. These new targets have the potential for incremental improvement in therapy. The transforming technology will be therapeutic vaccination and some breakthroughs have been reported within the last year. Stay tuned!

starting meds after 8 yr. diagnosis
Not a Question Just an Update

  • Email Email
  • Glossary Glossary

 Get Email Notifications When This Forum Updates or Subscribe With RSS



This forum is designed for educational purposes only, and experts are not rendering medical, mental health, legal or other professional advice or services. If you have or suspect you may have a medical, mental health, legal or other problem that requires advice, consult your own caregiver, attorney or other qualified professional.

Experts appearing on this page are independent and are solely responsible for editing and fact-checking their material. Neither nor any advertiser is the publisher or speaker of posted visitors' questions or the experts' material.

Review our complete terms of use and copyright notice.

Powered by ExpertViewpoint